I think BIS is not covered by Medicare in Australia. That is why they have to concentrate on the US (also a larger market) If anyone knows more, please add.
I agree, I would rather see a pay per use model. It would seem so much simpler, but they won't move to it, at least not yet.
Ann: New Clinical Practice Guidance Recommends Use of BIS, page-63
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IPD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.8¢ |
Change
-0.001(1.69%) |
Mkt cap ! $117.3M | |||
| Open | High | Low | Value | Volume |
| 6.0¢ | 6.0¢ | 5.8¢ | $48.02K | 820.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 223375 | 5.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.0¢ | 204460 | 2 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| IPD (ASX) Chart |